[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wojcikiewicz et al., 1998 - Google Patents

Differences among type I, II, and III inositol-1, 4, 5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1, 4, 5 …

Wojcikiewicz et al., 1998

View PDF
Document ID
5907292558099147393
Author
Wojcikiewicz R
Luo S
Publication year
Publication venue
Molecular pharmacology

External Links

Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans

Similar Documents

Publication Publication Date Title
Wojcikiewicz et al. Differences among type I, II, and III inositol-1, 4, 5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1, 4, 5-trisphosphate
Ishihara et al. Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin
Chitaev et al. Adhesive but not lateral E-cadherin complexes require calcium and catenins for their formation
Zhang et al. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific β1 integrins
Isenman et al. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Nesterov et al. Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant μ2 subunit and its effects on endocytosis
Asazuma et al. Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets
El-Daher et al. Distinct localization and function of1, 4, 5IP3 receptor subtypes and the1, 3, 4, 5IP4 receptor GAP1IP4BP in highly purified human platelet membranes
Huang et al. Pannexin1 is expressed by neurons and glia but does not form functional gap junctions
Brdička et al. Non–T Cell Activation Linker (NTAL) A Transmembrane Adaptor Protein Involved in Immunoreceptor Signaling
Hughes et al. CLEC-2 activates Syk through dimerization
Gwack et al. Biochemical and functional characterization of Orai proteins
Bruyns et al. T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR–CD3–ζ complex, recruits intracellular signaling proteins to the plasma membrane
Pizard et al. Bradykinin-induced internalization of the human B2receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail
Pelchen‐Matthews et al. Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells.
Wälde et al. The Nucleoporin Nup 358/Ran BP2 Promotes Nuclear Import in a Cargo‐and Transport Receptor‐Specific Manner
Thornton et al. Spatial and temporal regulation of RACK1 function and N-methyl-D-aspartate receptor activity through WD40 motif-mediated dimerization
Reid et al. The α, but not the β, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization: independent modulation of Tpα signaling by nitric oxide and prostacyclin
Snyers et al. Cysteine 29 is the major palmitoylation site on stomatin
Biocca et al. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization
Kurihara et al. Characterization of a phosphorylation event resulting in upregulation of the salivary Na+-K+-2Cl− cotransporter
Brouns et al. The structure of the μ/pseudo light chain complex on human pre‐B cells is consistent with a function in signal transduction
Fujino et al. Differential Regulation of Prostaglandin F2αReceptor Isoforms by Protein Kinase C
Bu et al. ERD2 proteins mediate ER retention of the HNEL signal of LRP’s receptor-associated protein (RAP)
Boundy et al. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.